Combination teletherapy and iridium implantation in the treatment of locally advanced breast cancer.
Combined teletherapy and interstitial iridium 192 implantation can control locally advanced breast cancer in a consistent fashion without causing significant morbidity. Moreover, in the absence of clinically evident distant metastases, patients who undergo this treatment can survive comfortably for long periods of time. Among 11 patients followed for at least 1 1/2 years, nine are alive without evidence of disease, one is living with distant metastases, and one patient is dead. There has been no local recurrence in the 18 patients included in this report.
D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000532:radiotherapy*; D003037:Cobalt Radioisotopes / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007495:Iridium / Q000627:therapeutic use*; D008875:Middle Aged; D011867:Radioisotope Teletherapy; D011868:Radioisotopes / Q000627:therapeutic use*; D011882:Radiotherapy, High-Energy
D003037:Cobalt Radioisotopes; D011868:Radioisotopes; D007495:Iridium